A pancreas tumor database study
Part of Cancer clinical trials.
This study collects information from multiple centers about a rare pancreas tumor called solid pseudopapillary neoplasm (SPN). It will help doctors learn more about this condition and how to best care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with solid pseudopapillary neoplasm (SPN) of the pancreas, confirmed by a biopsy or pathology report.
- You need to be willing to come back for follow-up visits as scheduled.
- Anyone of any age or health status can join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.
This trial tests a new approach that combines a special biopsy needle with immediate on-site checking to better diagnose solid pancreas masses. It may help get a clearer diagnosis in one procedure.
This study collects information from patients with pancreatic cancer that has a specific genetic change called a KRAS mutation, who have already received treatment targeting this mutation. Researchers will track outcomes to better understand how these treatments work.
This study checks how your digestion and daily social functioning may change after surgery. It looks at results from completed questionnaires filled out after your diagnosis to understand what issues patients face.
This study builds a database of people diagnosed with pancreatic tumors. It may help researchers better understand these cancers by collecting medical information over time.
This study collects information from adults who have surgery for pancreatic cancer. It may help researchers better understand outcomes and improve future care.
Hear when a new Solid Pseudopapillary Neoplasm of the Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.